Ind-Swift Laboratories Q2 Results
- BSE: 532305
- NSE: INDSWFTLAB
- ISIN: INE915B01019
- Sector: Major Drugs
BSE
99.85
-2.00 (-1.96%)
-2.00 (-1.96%)Volume4.51 K
Updated: Mon 25 Nov, 2024 | 15:15:00
NSE
98.63-2.02 (-2.01%)
-2.02 (-2.01%)Volume37.50 K
Updated: Mon 25 Nov, 2024 | 15:15:08
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹11.96 Cr.(-63.95%)
- Operating Profit₹-12.01 Cr.(20.21%)
- Profit After Tax₹0.41 Cr.(-55.82%)
- Operating Margin-100.45%(NA%)
Note: Comparison is on YoY basis
Quarterly - Ind-Swift Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 11.96 | 310.34 | -% | 289.71 | -% |
| Selling/ General/ Admin Expenses Total | 5.80 | 39.02 | -% | 37.46 | -% |
| Depreciation/ Amortization | 0.22 | 13.89 | -% | 13.19 | -% |
| Other Operating Expenses Total | 9.63 | 48.76 | -% | 42.11 | -% |
| Total Operating Expense | 23.97 | 263.92 | -% | 237.20 | -% |
| Operating Income | -12.01 | 46.41 | -% | 52.51 | -% |
| Net Income Before Taxes | 0.58 | 31.64 | -% | 38.77 | -% |
| Net Income | 0.41 | 17.24 | -% | 31.66 | -% |
| Diluted Normalized EPS | 0.07 | 2.92 | -% | 5.36 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST - Markets
02C2C Advanced Systems IPO Day 2: Check GMP, subscription status and other key details
2 min read06:59 PM IST - Markets
03Stocks to buy or sell: Dharmesh Shah of ICICI Securities recommends buying L&T, Syngene International on November 25
5 min read10:00 AM IST